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i.org/1trocardiogram (ECG) patterns in a large multicenter cohort of patients with hypertrophic
cardiomyopathy; 1,004 consecutive patients with hypertrophic cardiomyopathy and a
recorded standard ECG (64% men, mean age 50 – 16 years) were evaluated at 4 Italian
centers. The study end points were sudden cardiac death (SCD) or surrogates, including
appropriate implanted cardiac defibrillator discharge and resuscitated cardiac arrest and
major cardiovascular events (including SCD or surrogates and death due to heart failure,
cardioembolic stroke, or heart transplantation). Prevalence of baseline electrocardiographic
characteristics was: normal ECG 4%, ST-segment depression 56%, pseudonecrosis waves
33%, “pseudoeST-segment elevation myocardial infarction (STEMI)” pattern 17%, QRS
duration ‡120 ms 17%, giant inverted T waves 6%, and low QRS voltages 3%. During a
mean follow-up of 7.4 – 6.8 years, 77 patients experienced SCD or surrogates and 154
patients experienced major cardiovascular events. Independent predictors of SCD or sur-
rogates were unexplained syncope (hazard ratio [HR] 2.5, 95% confidence interval [CI] 1.4
to 4.5, p[ 0.003), left ventricular ejection fraction <50% (HR 3.5, 95% CI 1.9 to 6.7, p [
0.0001), nonsustained ventricular tachycardia (HR 1.7, 95% CI 1.1 to 2.6, p [ 0.027),
pseudo-STEMI pattern (HR 2.3, 95% CI 1.4 to 3.8, p[ 0.001), QRS duration ‡120 ms (HR
1.8, 95% CI 1.1 to 3.0, p[ 0.033), and low QRS voltages (HR 2.3, 95% CI 1.01 to 5.1, p[
0.048). Independent predictors of major cardiovascular events were age (HR 1.02, 95% CI
1.01 to 1.03, p [ 0.0001), LV ejection fraction <50% (HR 3.73, 95% CI 2.39 to 5.83, p [
0.0001), pseudo-STEMI pattern (HR 1.66, 95% CI 1.13 to 2.45, p [ 0.010), QRS duration
‡120 ms (HR 1.69, 95% CI 1.16 to 2.47, p[ 0.007), and prolonged QTc interval (HR 1.68,
95% CI 1.21 to 2.34, p [ 0.002). In conclusion, a detailed qualitative and quantitative
electrocardiographic analyses provide independent predictors of prognosis that could be
integrated with the available score systems to improve the power of the current model. 
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0.1016/j.amjcard.2016.05.023cohort studies, have been related to worse prognosis. How-
ever, risk stratification is still largely unsatisfactory because of
the low positive predictive value of these predictors.1,2 In
recent years, the standard electrocardiogram (ECG) has been
shown to provide useful prognostic indications in patients
with HC. A normal ECG is generally associated with a mild
phenotype and favorable outcome, whereas marked electro-
cardiographic abnormalities have been shown to be correlated
with severe hypertrophy and the presence of myocardial
fibrosis.3,4 However, this universally available, low-cost, and
reproducible technique has rarely been tested in multivariable
models for SCD and major cardiovascular events’ risk strat-
ification.3e5 In the present study, we aimed to conduct an
extensive qualitative and quantitative electrocardiographic
analysis to assess the independent long-term predictive value
of specific ECG patterns for prognosis in a large, multicenter
HC cohort.www.ajconline.org
2 The American Journal of Cardiology (www.ajconline.org)Methods
In this retrospective observational study, we analyzed
1,047 consecutive patients evaluated from 1981 to 2011 at 4
Italian centers (S. Orsola-Malpighi Hospital, University of
Bologna, Bologna, Italy [n ¼ 452], Sapienza University of
Rome, Rome, Italy [n ¼ 296], Azienda Ospedaliera Care-
ggi, Florence, Italy [n ¼ 233], Monaldi Hospital, University
of Naples, Naples, Italy [n ¼ 66]) with unequivocal diag-
nosis of HC and a good-quality12-lead ECG obtained at first
evaluation. HC was diagnosed by the presence of hyper-
trophied and nondilated left ventricle (wall thickness
15 mm in adults) at transthoracic echocardiogram, in the
absence of other cardiac or systemic conditions that could
produce a comparable magnitude of LV hypertrophy.2
Forty-three patients (4%) were excluded for the following
reasons: (1) inadequate technical electrocardiographic
quality (n ¼ 14); (2) presence of paced ventricular rhythm
(n ¼ 15); and (3) percutaneous septal alcohol ablation or
myectomy preceding first evaluation (n ¼ 14). Therefore,
1,004 patients constituted the final study population.
The study end points were (1) SCD or surrogates, defined
as unexpected collapse occurring <1 hour from the onset of
symptoms in a patient who had previously experienced a
relatively uneventful clinical course or unexpected unwit-
nessed death or aborted cardiac arrest or appropriate
implantable cardioverter defibrillator (ICD) therapy (for
ventricular tachycardia/fibrillation with a heart rate 200
beats/min).6 (2) Major cardiovascular events, defined as
SCD or surrogates, death due to heart failure or car-
dioembolic stroke, or heart transplantation.6 Follow-up was
obtained by scheduled or nonscheduled clinical evaluations.
For patients who had not been evaluated clinically for
>1 year, follow-up was obtained by telephone interview or
by contacting the general practitioner.
The scalar 12-lead ECGs (standard calibration 10 mm/
1 mV) at first evaluation were performed on commercially
available instruments in the supine position during quiet
respiration and recorded at a paper speed of 25 mm/s. The
following parameters were measured: PR interval, QRS
duration, QRS voltages, QT interval, and corrected QT in-
terval (Bazett’s formula). Left bundle branch block (LBBB)
or right bundle branch block, left anterior fascicular block,
and nonspecific intraventricular conduction disturbance
were classified according to international criteria.7 A num-
ber of electrocardiographic criteria proposed for the clinical
identification of LV hypertrophy were used, including
Cornell voltage score (SV3 þ R aVL 20 mm in women
and 28 mm in men), modified Sokolow-Lyon score (SV1
or SV2 þ RV5 or RV6 35 mm), the amplitude of R wave
in aVL (11 mm), and the sum of RDI and SDIII
(25 mm). LV hypertrophy was diagnosed in the presence
of at least 1 criteria.8,9 Massive LV hypertrophy was defined
by modified Sokolow-Lyon score 50 mm.7
We defined specific ECG patterns. Pseudo-necrosis: pres-
ence of Q waves 1/3 of the ensuing R wave in depth and/or
0.04 seconds in duration in at least 2 contiguous leads except
aVR and/or the lack of progressive R-wave voltage increase in
the precordial leads.10 Low voltages: QRS complex amplitude
<0.5mV in all limb leads.11 Repolarization abnormalities: ST-
segment depression/elevation 0.1 mV below or above thebaseline at the J-point in at least 2 leads, except V1-V2-V3,
where it was considered only when0.2 mV.12 T waves were
defined as (1) “inverted” when the negative T-wave amplitude
was 0.1 mV, (2) “giant negative” when amplitude was
1.0 mV,12 and (3) “giant positive” T waves were defined as
symmetrical positive T waves 1.0 mV.13 ST-segment
elevation and giant positive T waves were considered only in
the absence ofLBBB.The presenceof notching in terminal part
of QRS was defined as “J wave.” A specific ECG pattern
characterized by the presence of ST-segment elevation and/or
giant positive T waves in at least 2 contiguous leads in the
absence of LBBB was assessed and defined “pseudoeST-
segment elevation myocardial infarction (STEMI)” pattern for
its resemblance of the ECG associated with the acute/subacute
phase of myocardial infarction (Figure 1).14 Other prespecified
ECG patterns such as massive LV hypertrophy, massive LV
hypertrophy associated with right atrial enlargement, and LV
hypertrophywith abnormalR/S inV1were assessed.All ECGs
were independently analyzed using manual calipers, and pat-
terns were adjudicated by 2 independent investigators (EB and
CP—S.Orsola Malpighi Hospital Bologna) unaware of the
clinical details of the patients.Discrepancieswere resolved by a
senior supervisor (CR).
Standard M-mode and 2-dimensional echocardiographic
studies were performed by commercially available in-
struments to identify and qualify morphologic features of
the left ventricle. The greatest wall thickness measured at
any site in the LV wall was regarded as the maximal
thickness,6 independently of body surface area and gender
or age. LV outflow obstruction in basal conditions was
defined as a peak outflow gradient of 30 mm Hg, as
estimated by continuous-wave Doppler echocardiography.15
Continuous data were expressed as mean value  SD.
Data were compared by the chi-square analysis for pro-
portions and Student’s t test for continuous variables. Sur-
vival rates were obtained using Kaplan-Meier method of
estimation. Univariate and multivariable Cox proportional
hazard regression models were constructed to identify in-
dependent predictors of follow-up events. Each electrocar-
diographic variable was assessed by Cox proportional
univariate survival analysis. Model building followed a
backward stepwise approach with entry set at a significance
level of 0.1. For each variable, the hazard ratio (HR) with a
corresponding 95% confidence interval was reported. Har-
rell’s C index was used to assess model’s discrimination. A
p value <0.05 was considered statistically significant. Sta-
tistical analyses were obtained using Stata/SE 13.1 (Stata-
Corp IP, College Station, Texas).
Results
Clinical and echocardiographic characteristics and
arrhythmic risk profile of the study population are listed in
Table 1. In our population, 29 patients had an ICD at first
evaluation and 150 underwent ICD implantation during
follow-up.
Electrocardiographic variables are listed in Table 2. The
pseudo-STEMI pattern was present in 171 patients (17%)
including 97 patients with ST-segment elevation, 34 with
giant positive T waves, and 40 with both. One hundred
twenty-one patients (71%) showed this pattern in anterior
Figure 1. Electrocardiographic examples of the pseudo-STEMI pattern.
Cardiomyopathy/ECG Patterns and Cardiac Death in HC 3leads, 27 patients (16%) in inferior leads, 15 patients (9%) in
inferolateral leads, and 8 patients (5%) only in lateral leads.
A short PR interval (120 ms) was present in 71 cases.
After a mean follow-up of 7.4  6.8 years, 77 patients
experienced SCD or surrogates including 41 who actually
died suddenly (4%), 24 with appropriate ICD discharge
(2%), and 12 with aborted cardiac arrest (1%). A total of 154
patients (15%) experienced major cardiovascular events,
including the 77 with SCD or surrogates, 60 (6%) with heart
failureerelated death (15 of which underwent heart trans-
plantation), and 17 (2%) who died after cardioembolic
stroke. The electrocardiographic findings associated with
SCD or surrogates at univariate analysis were QRS 120
ms, pseudo-STEMI pattern, ST-segment elevation, and low
QRS voltages (Table 3). The electrocardiographic findings
associated with major cardiovascular events at univariate
analysis were QRS 120 ms, prolonged corrected QT in-
terval, left and right atrial enlargement, and pseudo-STEMI
pattern (Table 3).
At multivariable analysis (Table 4), unexplained syncope
(hazard ratio [HR] 2.47, 95% confidence interval [CI] 1.37
to 4.47, p ¼ 0.003), nonsustained ventricular tachycardia(NSVT) during Holter monitoring (HR 1.68, 95% CI 1.06 to
2.65, p ¼ 0.027), LV ejection fraction <50% (HR 3.55,
95% CI 1.89 to 6.66, p ¼ 0.0001), pseudo-STEMI pattern
(HR 2.28, 95% CI 1.38 to 3.77, p ¼ 0.001), QRS duration
120 ms (HR 1.78, 95% CI 1.05 to 3.03, p ¼ 0.033), and
low QRS voltages (HR 2.26, 95% CI 1.01 to 5.07, p ¼
0.048) were independently associated with SCD or surro-
gates. Harrell’s C index was 0.68. Sensibility and specificity
of QRS duration in predicting SCD were 26% and 84%,
respectively; positive and negative predictive values were
12% and 93%, respectively. Sensibility and specificity of
pseudo-STEMI pattern in predicting SCD were 30% and
84%, respectively; positive and negative predictive values
were 13% and 93%, respectively. Sensibility and specificity
of low QRS voltages in predicting SCD were 9% and 97%,
respectively; positive and negative predictive values were
21% and 93% respectively.
Multivariable Cox proportional model for major cardio-
vascular events (Table 4) identified age (HR 1.02, 95% CI
1.01 to 1.03, p ¼ 0.0001), LV ejection fraction <50% (HR
3.73, 95% CI 2.39 to 5.83, p ¼ 0.0001), pseudo-STEMI
pattern (HR 1.66, 95% CI 1.13 to 2.45, p ¼ 0.010), QRS
Table 2
Baseline electrocardiographic characteristics of the study population
Characteristics Prevalence
Normal ECG 38 (4%)
QRS duration 120msec 172 (17%)
Prolonged corrected QT interval (440 msec) 297 (30%)
Prolonged corrected QT interval ( 480 msec) 65 (6%)
Left atrial enlargement 448 (45%)
Right atrial enlargement 85 (8%)
LV hypertrophy* 562 (56%)
Massive LV hypertrophy 139 (14%)
Massive LV hypertrophy associated to right
atrial enlargement
11 (1%)
LV hypertrophy in presence of abnormal R/S in V1 23 (2%)
Low QRS voltages 33 (3%)
Pseudo-necrosis Q waves 335 (33%)
Repolarisation abnormalities 778 (77%)
Negative T wave 746 (74%)
Giant inverted T waves (10 mm) 56 (6%)
Giant positive T waves (10 mm) 74 (7%)
ST-segment depression 557 (56%)
ST-segment elevation 137 (14%)
“Pseudo-STEMI” pattern 171 (17%)
ST segment elevation without giant positive T waves 97 (10%)
Giant positive T waves without ST segment elevation 34 (3%)
ST segment elevation and giant T waves 40 (4%)
J wave 34 (3%)
Abnormal R/S wave in V1 60 (6%)
Complete RBBB 67 (7%)
Complete LBBB 63 (6%)
Unspecified intraventricular block 73 (7%)
Left anterior fascicular block 133 (13%)
ECG ¼ electrocardiogram; HC ¼ hypertrophic cardiomyopathy; LV ¼
left ventricle; NSVT ¼ non sustained ventricular tachycardia.
* At least 1 criteria satisfied.
Table 1
Baseline characteristics of the study population (n ¼ 1004)
Variable
1004
 Age  18 984 (98 %)
 Age 14-17 20 (2%)
Males 640 (64%)
Age (years), mean  SD 50  16
Family history of HC 441 (44%)
Family history of SCD 196 (20%)
LV outflow tract obstruction (30 mmHg) 335 (33%)
Unexplained syncope 91 (9%)
NSVT on Holter monitoring 281 (28%)
NYHA functional class III-IV 71 (7%)
Maximal LV wall thicknes (mm) mean  SD/n patients* 20  5/997
LV end-diastolic dimension, (mm) mean  SD/n patients* 45  7/955
LV ejection fraction <50% 51 (5%)
Dilated-hypokinetic evolution 44 (4%)
HC ¼ hypertrophic cardiomyopathy; LV ¼ left ventricle; NYHA ¼ New
York Heart Association; NSVT ¼ nonsustained ventricular tachycardia;
SCD ¼ sudden cardiac death.
* Data missing: n patients with available data.
4 The American Journal of Cardiology (www.ajconline.org)duration 120 ms (HR 1.69, 95% CI 1.16 to 2.47, p ¼
0.007), and prolonged QTc interval (HR 1.68, 95% CI 1.21
to 2.34, p ¼ 0.002) as independent predictors. Harrell’s C
index was 0.71.
Kaplan-Meier survival curves for the end point SCD or
surrogates in patients with and without the pseudo-STEMI
pattern and QRS duration 120 ms are reported in
Figure 2. Survival curves were also constructed stratifying
the patients according to the number of risk factors (n ¼ 0,
n ¼ 1, n  2). In Figure 2, patients were stratified according
to the presence of the 4 conventional risk factors for SCD
(family history of SCD, unexplained syncope, NSVT during
24-hour Holter monitoring, and maximal LV wall thickness
30 mm). The annual SCD event rate in patients with no
risk factors was 0.62%, 1.19% in patients with 1 risk factor,
and 1.92% in patients with 2 risk factors (log-rank test p
value ¼ 0.0006). The addition of the 3 electrocardiographic
variables independently related to SCD improved the model
(Figure 2). In patients with no risk factors, the annual SCD
event rate was 0.38% and was 0.91% and 1.94% in patients
with 1 and 2 risk factors, respectively (log-rank test p
value ¼ 0.00001). The Cox proportional hazard regression
model stratified the patients well according to the number of
the conventional risk factors; however, the addition of the
electrocardiographic variables in a second model resulted in
a higher predictive power for SCD (chi-square from 14 to
32, p value 0.0001).Discussion
This study highlights the potential contribution of stan-
dard ECG—interpreted with a quantitative and qualitative
approach—to risk stratification of patients with HC.
Different ECG patterns can be observed and their recogni-
tion can contribute to guide the physician toward a correct
differential diagnosis and to stratify the risk of SCD and
major cardiovascular events.3,4The proportion of our cases with normal ECG (4%) is
similar with that reported from other groups.3 “Repolariza-
tion abnormalities” was the commonest single abnormality
(77%), followed by LV hypertrophy (56%), left atrial
enlargement (45%), and pseudonecrosis Q waves (33%).
Interestingly, some patterns were observed, including
pathologic Q waves with positive T waves in the same lead
(“Q/T discordance,” 24%), tall R waves in V1-V2 (R S) in
the context of LV hypertrophy (6%), right atrial enlargement
and LV hypertrophy (2%), giant negative T waves in the
precordial leads (1%), low QRS voltages (3%), and pseudo-
STEMI pattern (17%). The relation between ECG and
prognosis in HC has been investigated with conflicting re-
sults in the past.3e5,16e22 Studies have focused mainly on
the degree of LV hypertrophy and the overall electrical
instability, expressed by QT duration and dispersion and by
T-wave complexity.16e22 The sole presence of an “abnormal
ECG” has been found to be associated with a more severe
HC phenotype and worse cardiovascular outcome—
compared with a normal ECG—in 2,485 patients with HC.3
The main finding of our study is that specific features of
the standard ECG, namely QRS duration 120 ms, pseudo-
STEMI pattern, and low QRS voltages, are independent risk
factors for SCD or surrogates (Table 4) and could be usefully
integrated with the traditional risk factors (Figure 2). Whereas
pseudo-STEMI pattern and QRS duration >120 ms, together
Table 3
Univariate analysis in the overall population
Characteristics SCD or surrogates
Univariate Analysis
Major cardiovasculare events
Univariate Analysis
H.R. (95% CI) P value H.R. (95% CI) P value
Age 0.99 (0. 98 - 1.01) 0.610 1.02 (1.01 - 1.03) 0.0001
Male 0.83 (0.49 - 1.43) 0.268 1.20 (0.87 - 1.66) 0.286
Family history of SCD 1.66 (0.97 - 2.84) 0.007 1.86 (1.33 - 2.61) 0.0001
Familiar HC 1.92 (1.16 - 3.19) 0.011 1.57 (1.14 - 2.16) 0.006
Unexplained syncope 2.51 (1.34 - 4.73) 0.004 1.48 (0.89 - 2.46) 0.128
NSVT 24 hour Holter monitoring 1.81 (1.11 - 2.98) 0.024 1.47 (1.07 - 2.65) 0.018
Maximal LV wall thickness 1.38 (0.93 - 2.04) 0.419 1.12 (0.85 - 1.46) 0.420
Maximal LV wall thickness  3 cm 1.51 (0.74 - 3.06) 0.274 1.40 (0.86 - 2.27) 0.170
LV end-diastolic dimension 1.12 (0.72 - 1.75) 0.017 1.71 (1.32 - 2.22) 0.0001
LV outflow tract obstruction 1.05 (0.60 - 1.82) 0.675 0.98 (0.67 - 1.42) 0.905
LV ejection fraction < 50% 4.47 (2.44 - 8.18) 0.0001 4.52 (2.95 - 6.94) 0.0001
Normal ECG 0.35 (0.05 - 2.52) 0.297 0.34 (0.08 - 1.39) 0.135
QRS duration 120msec 2.09 (1.25 - 3.49) 0.005 2.59 (1.84 - 3.66) 0.0001
Prolonged corrected QT interval (440 msec) 1.56 (0.99 - 2.47) 0.056 1.86 (1.35 - 2.56) 0.0001
Prolonged corrected QT interval ( 480 msec) 1.23 (0.54 - 2.85) 0.618 2.45 (1.58 - 3.80) 0.0001
Left atrial enlargement 1.31 (0.79 - 2.16) 0.288 1.53 (1.08 - 2.16) 0.015
Right atrial enlargement 0.89 (0.36 - 2.21) 0.803 1.85 (1.12 3.03) 0.015
LV hypertrophy* 0.90 (0.57 - 1.42) 0.654 1.06 (0.76 1.46) 0.733
Massive LV hypertrophy 0.97 (0.51 - 1.83) 0.917 0.92 (0.58 - 1.46) 0.724
Massive LV hypertrophy associated to right atrial enlargement 1.05 (0.15 - 7.46) 0.956 1.68 (.53 - 5.28) 0.375
LV hypertrophy in presence of abnormal R/S in V1 0.66 (0.09 - 4.79) 0.686 1.79 (0.73 - 4.37) 0.201
Low QRS voltages 2.71 (1.24 - 5.91) 0.012 1.80 (0.91 - 3.53) 0.089
Pseudo-necrosis Q waves 1.35 (0.86 - 2.13) 0.191 1.03 (0.74 - 1.43) 0.858
Repolarisation abnormalities 1.09 (0.61 - 2.0) 0.754 1.08 (0.71 - 1.63) 0.715
Negative T wave 0.66 (0.36 - 1.19) 0.170 0.85 (0.58 - 1.25) 0.409
Giant inverted T waves (10 mm) 0.36 (0.09 - 1.46) 0.152 0.44 (0.18 - 1.07) 0.152
Giant positive T waves (10 mm) 0.94 (0.51 - 1.75) 0.493 1.25 (0.72 - 1.73) 0.407
ST-segment depression 1.07 (0.67 - 1.70) 0.772 1.15 (0.83 - 1.61) 0.389
ST-segment elevation 2.42 (1.50 - 3.89) 0.004 1.45 (0.99 - 2.12) 0.525
“Pseudo-STEMI” pattern 2.07 (1.26 - 3.38) 0.0001 1.60 (1.07 - 2.35) 0.020
J wave 1.93 (0.78 - 4.80) 0.154 1.93 (0.78 - 4.80) 0.154
Abnormal R/S wave in V1 0.40 (0.09 - 0.64) 0.207 1.03 (0.54 - 1.97) 0.914
Left anterior fascicular block 0.87 (0.44 - 1.70) 0.682 0.89 (0.56 - 1.42) 0.646
ECG ¼ electrocardiogram; HC ¼ hypertrophic cardiomyopathy; LV ¼ left ventricle; NSVT ¼ non sustained ventricular tachycardia; SCD ¼ sudden cardiac
death.
* At least 1 criteria satisfied.
Table 4
Multivariate analysis in the overall population
Variables SCD or surrogates
Multivariable analysis
Major cardiovascular events
Multivariable analysis
H.R. (95% CI) P value H.R. (95% CI) P value
Age 1.02 (1.01 - 1.03) 0.0001
Unexplained syncope 2.47 (1.37 - 4.47) 0.003
NSVT 24 hour Holter monitoring 1.68 (1.06 - 2.65) 0.027
LV ejection fraction <50% 3.55 (1.89 - 6.66) 0.0001 3.73 (2.39 - 5.83) 0.0001
QRS duration 120 msec 1.78 (1.05 - 3.03) 0.033 1.69 (1.16 - 2.47) 0.007
Low QRS voltages 2.26 (1.01 - 5.07) 0.048
“Pseudo STEMI” pattern 2.28 (1.38 - 3.77) 0.001 1.66 (1.13 - 2.45) 0.010
Prolonged QTc interval (440 msec) 1.68 (1.21 - 2.34) 0.002
LV ¼ left ventricle; NSVT ¼ non sustained ventricular tachycardia; SCD ¼ sudden cardiac death.
Cardiomyopathy/ECG Patterns and Cardiac Death in HC 5with prolonged QTc interval, were found to be independent
predictors not only of SCD and surrogates but of all the major
cardiovascular events, they have been analyzed in detail.The negative prognostic role of prolonged QRS duration
is somewhat expected and, indeed, has been reported by
Bongioanni et al16 as regard to HC-related death.5 An
Figure 2. Kaplan-Meier survival curves for the end point SCD or surrogates according to the presence/absence of the pseudo-STEMI pattern (panel A) and QRS
duration 120 ms (panel B). (Panels C and D) Kaplan-Meier survival curves for the end point SCD or surrogates stratifying the patients according to the
number of conventional risk factors (family history of SCD, unexplained syncope, nonsustained ventricular tachycardia during electrocardiographic Holter
monitoring, maximum wall thickness 30 mm), or after the addition of the 3 ECG patterns (pseudo-STEMI pattern, QRS duration 120ms, and low QRS
voltages).
6 The American Journal of Cardiology (www.ajconline.org)association with apical aneurism development has also been
reported by other investigators. QRS prolongation in
(dilated) cardiomyopathies is accepted as a marker of
myocardial damage and as a factor of contractile dysfunc-
tion.23,24 Our study extends the independent prognostic
value of this pattern to SCD or surrogates. Patients with
abnormally prolonged QRS duration tend to be older, have
more frequently a family history of SCD or NSVT during
Holter monitoring, and a higher frequency of LV dysfunc-
tion (Supplementary Table 1).
The independent prognostic significance of low QRS
voltages is interesting but unfortunately of little clinical
relevance because of the very low prevalence of this finding
(3%). In cardiomyopathies, low QRS voltages are often
secondary to the expansion of myocardial interstitial space
(amyloidosis, fibrosis, edema, and flogistic infiltrates) or to
diffuse myocellular damage.11 In HC, the mechanism has
yet to be investigated, but it could be related to a greater
degree of myocardial fibrosis. Unfortunately, the absence of
magnetic resonance imaging data did not allow us to
investigate the phenomenon. No association between low
QRS voltages and heart failure development during follow-
up and death due to heart failure and transplant were
recorded.
The pseudo-STEMI pattern has never been evaluated in
HC. In our study, this pattern (observed in 17%) is associ-
ated with a risk of SCD and surrogates and to major car-
diovascular events of 2.28 and 1.66, respectively, at themultivariable analysis. The high negative predictive value
(93%) is particularly intriguing. The reasons of this finding
are not clear, and our study does not have the characteristics
necessary to unravel the issue. It is notably that the pattern is
not associated with a more severe morphologic or
arrhythmic phenotype. Patients with the pseudo-STEMI
pattern were younger, more frequently men, and with a
higher rate of LV outflow obstruction (Supplementary
Table 1). It is reasonable that the peculiar repolarization
abnormality could be the expression of a genetically deter-
mined ion-channel dysfunction accidentally associated with
HC. Some published data are potentially in line with this
hypothesis. Lopes et al25 documented a very high number of
sarcomeric and nonsarcomeric genetic variants associated
with the classic HC mutations and hypothesized that some
of these variants could influence the expression of HC
phenotype. In HC probands, a relation between rare variants
in the SCN5A gene and left atrial enlargement at last eval-
uation or LV outflow obstruction have been reported.25
Additionally, SCN5A variants appear to influence the
fibrotic process in patients with sarcomeric protein muta-
tions.26 A similar explanation (i.e., involving ion channels)
has been proposed for the cases of SCD associated with
early repolarization in the general population.27,28 In our
series, however, the prevalence of early repolarization,
defined as the sole presence of J wave (3%), is decidedly
low and prognostically irrelevant. A single study on a small
cohort of patients with HC29 reports a prevalence of early
Cardiomyopathy/ECG Patterns and Cardiac Death in HC 7repolarization (defined as J-point elevation 0.1 mV in at
least 2 consecutive inferior/lateral leads excluding V1-V2-
V3) of 12% and found that the presence of a J wave was
more frequent in patients who died suddenly. Prospective
studies are required to test these hypothesis.
Beyond the incomplete understanding of the mecha-
nisms, it is noteworthy that when added to the conventional
SCD risk factors, electrocardiographic variables, despite
their low positive predictive value, improved the risk strat-
ification model (Figure 2), especially the ability to identify
subjects at very low risk (annual SCD or surrogates rate in
patients without any conventional risk factors or electro-
cardiographic markers is 0.3%). It should be noted that
survival curves of patients with/without prolonged QRS
tend to diverge soon after the initial observation, differently
from what occurs with the pseudo-STEMI pattern. These
new observations may be included in the recently proposed
algorithm for quantitative 5-year risk calculation.1
The main limitations of this study are the retrospective
design that may have introduced a selection bias and the
relatively small size that may have limited the prognostic
significance of the statistical analysis. Also, appropriate ICD
activation is a surrogate marker of sudden death and its use
for outcome analysis may have led to an overestimation of
events. Because of the lack of genetic data, we can only
speculate that ion-channel mutations could be associated
with the pseudo-STEMI pattern, and further prospective
studies are required to investigate this hypothesis.
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